Biotechnology, a specialty sector that lost favor along with technology funds, appears to be making a comeback, judging from a very strong offering by two private-equity biotechnology funds, Reuters reports.
Venture capital firm
In fact, the American Stock Exchange Biotechnology Index is up 42% since March. In fact, more than 50 biotechnology companies in Europe are planning initial public offerings, according to
__
The staff of Money Management Executive ("MME") has prepared these capsule summaries based on reports published by the news sources to which they are attributed. Those news sources are not associated with MME, and have not prepared, sponsored, endorsed, or approved these summaries.
